Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.
about
The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaBmiRNAs as Biomarkers in Chronic Myelogenous LeukemiaTyrosine kinase chromosomal translocations mediate distinct and overlapping gene regulation events.Identification of genes potentially involved in disease transformation of CML.Gene expression changes associated with progression and response in chronic myeloid leukemia.Microarray-based expression profiling of normal and malignant immune cellsHigh affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia.Advances in targeted therapy for chronic myeloid leukemia.Gene expression profiling and its application in studies of haematological malignancy.DNA micro-array analysis of myelodysplastic syndrome.Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia.PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells.Role of gene-expression profiling in chronic myeloid leukemia.miRNAs in chronic myeloid leukemia: small molecules, essential function.Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients.A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation.Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders.DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes.Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.Genome-wide approach to identify risk factors for therapy-related myeloid leukemia.DNA microarray analysis of hematopoietic stem cell-like fractions from individuals with the M2 subtype of acute myeloid leukemia.Chronic myelogenous leukemia molecular signature.DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions.Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.
P2860
Q24295552-7C989690-F437-4892-ABB8-0645926AB260Q28087081-64F75C17-7F1F-4331-9E99-9AD6FDE97493Q34113046-695D1664-4F5E-41FD-B6B0-B8FF659371E7Q34409580-F919B6A5-5C06-4731-9BEA-E108B8BBF07FQ34479561-AD3668CC-A7D4-4201-A48C-D831474DF893Q34671695-7B14C742-489A-49D2-ACB9-E3BF0ABAA1DBQ35104353-42B594E5-8AC7-4DF5-8F53-8B9A97DEB7EDQ35160190-37CF0389-2ECC-4062-80BA-EBE8F4BFB875Q35661018-3E2D2FC3-9468-4B2E-9660-D6B44E9C3B3EQ36328414-DC476730-F0E6-4A1A-8715-CE99C3BC1EDCQ37132871-97F20E7F-4F91-49C1-ABE4-1496AB95AAA3Q37214337-257AB993-99AF-49FA-A621-94C02BD7D8C5Q37810111-973BDAB0-5E9F-49F0-B0A4-D572418D5685Q38979577-3A14E66E-ED05-4207-9616-3F2522078060Q40312982-B3CD31F4-F59D-425B-AC11-10C0184AF3F7Q40321847-F147C644-4191-4D7A-850F-F8A3A4123A68Q40350288-9AE53D10-341F-4BA2-A0DC-71267011A8BCQ40639543-081E257E-76FD-45B4-BD40-4F6E534C5B10Q40715481-954EDE31-24A0-4A74-A6D1-FD8E0DE04216Q46418288-12A7D3EF-5CA9-46CD-92A5-6DD2C402A5CEQ46845159-AA1B735E-B71C-4DE1-921A-B2B7B5EDF7B8Q47601605-31F2BC48-07D0-4103-BD18-8B4B43007081Q47821781-C08D8594-6508-4694-AB47-3F40A5A87851Q52004795-F94FC8A9-CF68-4DE8-B794-D2E75597E033Q53347361-3F07D2DB-EFE6-46BF-BB5F-E1ACF0BB8B8D
P2860
Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Characterization of stage prog ...... fied hematopoietic stem cells.
@ast
Characterization of stage prog ...... fied hematopoietic stem cells.
@en
Characterization of stage prog ...... fied hematopoietic stem cells.
@nl
type
label
Characterization of stage prog ...... fied hematopoietic stem cells.
@ast
Characterization of stage prog ...... fied hematopoietic stem cells.
@en
Characterization of stage prog ...... fied hematopoietic stem cells.
@nl
prefLabel
Characterization of stage prog ...... fied hematopoietic stem cells.
@ast
Characterization of stage prog ...... fied hematopoietic stem cells.
@en
Characterization of stage prog ...... fied hematopoietic stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of stage prog ...... fied hematopoietic stem cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205029
P407
P577
2001-12-01T00:00:00Z
P5875
P6179
1044782379